施裕丰教授作为第一作者或通讯作者在Nature、Cell、Nature Immunology、Advanced Science 等权威杂志上发表代表性论文多篇，这些工作分别有同行在Nature Review Drug
Discovery以及Nature Review
Cancer、 Cell 、Nature Immunology等杂志进行亮点点评。施裕丰教授拥有1项国际发明专利，曾以共同主持人身份主持1项美国纪念斯隆-凯特琳癌症中心药物研究项目，参与2 项美国国家健康研究院（NIH）研究项目和3 项德克萨斯州肿瘤研究院项目。获得国自然面上基金两项。其工作成果曾获得全国百篇优秀论文、中国科学院百篇和谈家桢基金生命科学九源奖学金等一系列奖项。施裕丰教授亦是同济大学脑与脊髓研究中心“泰禾冠名教授“，入选“上海市海外高层次人才引进计划” ，“同济大学杰青培育计划”等。
专利
Substituted
benzimidazolium, pyrido-imidazolium, or pyrazino-imidazolium compounds
as chemotherapeutics. WO 2017100525 A1, Jun 15, 2017
学术论文
1. Shi Y., Lim SK., Liang
Q., Iyer S., Wang H., Wang Z., Xie X., Chen Y., Tabar V., Glutin P., Williams
N., De Brabander JK., and Parada LF. A novel oxidative phosphorylation
inhibitor targets glioblastoma. Nature, 2019
Mar; 567(7748):341-346. 第一作者，文章在Nature Review Drug
Discovery 和Nature Review
Cancer 上被亮点点评。
2. Shi, Y., Feng, Y., Kang,
J., Liu, C., Li, Z., Li, D., Cao, W., Bi, E., Zang, L., Lu, C.,
Zhang, J., and Pei, G. Critical regulation of CD4+ T cell survival and
autoimmunity by beta-Arrestin 1. Nat Immnol. 2007 8(8):817-824. 第一作者
3.
Kang, J*., Shi, Y*., Xiang,
B*., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. A
nuclear function of beta-arrestin1 in GPCR signaling regulation of histone
acetylation and gene transcription. Cell 2005 123,
833-847.1. (*These authors contributed equally to this paper) 共同一作
4. Shi, Y., Lim, SK.,
Parada, LF. The soft underbelly of tumor cells. Cell research, 2014 24:910–911 第一作者
5. Shi, Y., Stefan, C.,
Emr, S. Two novel WD40 domain-containing protein, Ere1 and Ere2, function in
the retromer-mediated endosomal recycling pathway. MBoC,
2011 Nov;22(21):4093-107. 第一作者
6.
Zilai Wang, Daochun Sun, Yu-Jung Chen,
Xuanhua Xie, Yufeng Shi, Viviane Tabar, Cameron W. Brennan Tejus
Bale, Chenura D. Jayewichreme, Dan R. Laks, Sheila Alcantara Llaguno and Parada
LF. Cell lineage-Based Stratification for glioblastoma. Cancer Cell, 2020
Sep;
7.
Shichao Huang2#*, Yu’e Liu1#, Yanan Zhang3#,
Ru Zhang1, ChengJie Zhu1, Lihong Fan1 , Gang Pei1,2, Bo Zhang3 *, Yufeng
Shi * Baicalein inhibits SARS-CoV-2/VSV replication with
interfering mitochondrial oxidative phosphorylation in a mPTP
dependent manner，Signal Transduction and Targeted Therapy, 2020 通讯作者
8.
Yu’e Liu#, Yufeng Shi*
Mitochondria as a target in cancer treatment. Medcomm,2020.9.1
(2):129-139 通讯作者
9. Ming Li # , Bingjie Hao # , Menghuan Zhang # , Russel J Reiter , Shumeng Lin , Tiansheng Zheng , Xiangyun Chen , Yanbei Ren , Liduo Yue , Baigenzhin Abay , Guojie Chen , Xiao Xu 1, Yufeng Shi* , Lihong Fan* Melatonin
enhances radiofrequency-induced NK antitumor immunity, causing cancer
metabolism reprogramming and inhibition of multiple pulmonary tumor
development. Signal Transduction and Targeted Therapy, 2021
共同通讯作者
10. Yu’e Liu#, Chao
Chen#, Xinye Wang, Yihong Sun, Juxiang Chen*, Yufeng Shi*, An
Epigenetic Role of Mitochondria in Cancer, Cells, 2022, 11(16),
2518; 通讯作者
11. Changqing Wu #1, Yu'e Liu #1, Wenju Liu# 2, Tianhui Zou# 3, Shaojuan Lu 1, Chengjie Zhu 1, Le He 1, Jie Chen 1, Lan Fang 1, Lin Zou 4, Ping Wang 1, Lihong Fan 5, Hongxiang Wang 6, Han You 7, Juxiang Chen* 6, Jing-Yuan Fang* 3, Cizhong Jiang *2, Yufeng Shi* 1 2 8 NNMT-DNMT1
Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative
Phosphorylation Inhibition Advanced Science 2022
DOI: 10.1002/advs.202202642 通讯作者
12. Yu’e Liu#*,
Yihong Sun#, Xiaoyun Shi#, Xi Chen, Yi Wang, Yufeng
Shi*, An Overview: The Diversified Role of Mitochondria in Cancer
Metabolism. International Journal of Biological Sciences 2023 通讯作者
13. Yue’Liu#,
Yanjin Wang#, Yanrong Yang#,, Linjun Weng, Qi Wu,
Jin Zhang, Pengcheng Zhao, Lan Fang*, Yufeng Shi*, Ping Wang*
Emerging phagocytosis checkpoints in cancer immunotherapy. Signal
Transduction and Targeted Therapy, 2023共同通讯
14. Yue’Liu#,
Weng Linjun#, Wang Yanjin#,, Qi Wu, Jin Zhang,
Pengcheng Zhao, Yufeng Shi*, Ping Wang*, Lan Fang*, Emerging
phagocytosis checkpoints in cancer immunotherapy. Journal of
Advanced Research, 2023共同通讯
15. Yuanpei Li #, Xiaoniu He # ,Xiao Lu , Zhicheng Gong , Qing Li , Lei Zhang , Ronghui Yang , Chengyi Wu , Jialiang Huang , Jiancheng Ding , Yaohui He , Wen Liu , Ceshi Chen , Bin Cao , Dawang Zhou , Yufeng Shi , Juxiang Chen , Chuangui Wang,
Shengping Zhang, WangJian Zhang , Jing Ye , Han You * METTL3
acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic
functions Nature Communications 2022 共同作者
16. Jin-Zhu Wang 1, Hong Zhu 1, Pu You 2, Hui Liu 1, Wei-Kang Wang 1, Xiaojuan Fan 3, Yun Yang 3, Keren Xu 4, Yingfeng Zhu 5, Qunyi Li 6, Ping Wu 7, Chao Peng 7, Catherine Cl Wong 7, Kaicheng Li 2, Yufeng Shi 8, Nu Zhang 9, Xiuxing Wang 10, Rong Zeng 4, Ying Huang 11, Liusong Yang 12, Zefeng Wang 3, Jingyi Hui 1 Upregulated
YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR
pathway The Journal of Clinical Investigation 2022.共同作者
17.
Chao Chen#, Yu’e
Liu#, Hongxiang#,
Wang, Xu Zhang, Yufeng
Shi*, Juxiang
Chen*, FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and
suppresses invasiveness in glioblastoma through a feedback loop of
FOXO1/miR-506/ETS1/FOXO1 Journal of
Zhejiang University-SCIENCE B，2023 Aug 15;24(8):698-710 共同通讯